Estrogens Protect against High-Fat Diet-Induced Insulin Resistance and Glucose Intolerance in Mice

Élodie Riant, Aurélie Waget, Haude Cogo, Jean‐François Arnal, Rémy Burcelin, Pierre Gourdy

The Journal of Clinical Endocrinology & Metabolism · 2009 · 19 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

Although corroborating data indicate that estrogens influence glucose metabolism through the activation of the estrogen receptor α (ERα), it has not been established whether this pathway could represent an effective therapeutic target to fight against metabolic disturbances induced by a high-fat diet. To this end, we first evaluated the influence of chronic 17β-estradiol (E2) administration in wild type ovariectomized mice submitted to either a normal chow diet (NCD) or a high-fat diet (HFD). Whereas only a modest effect was observed in NCD fed mice, E2 administration exerted a protective effect against HFD-induced glucose intolerance, and this beneficial action was abolished in ERα-deficient mice. Furthermore, E2 treatment reduced HFD-induced insulin resistance by 50% during hyperinsulinemic euglycemic clamp studies, and improved insulin signalling (Akt phosphorylation) in insulin-stimulated skeletal muscles. Unexpectedly, we found that E2 treatment enhanced cytokine (IL-6, TNF-α) and PAI-1 mRNA expression induced by HFD in the liver and visceral adipose tissue. Interestingly, although the pro-inflammatory effect of E2 was abolished in visceral adipose tissue from chimeric mice grafted with bone marrow cells from ER-deficient mice, the beneficial effect of the hormone on glucose tolerance was not altered, suggesting that the metabolic and inflammatory effects of estrogens can be dissociated. Eventually, comparison of sham-operated with ovariectomized HFD-fed mice, demonstrated that endogenous estrogens levels are sufficient to exert a full protective effect against insulin resistance and glucose intolerance. In conclusion, the regulation of the ERα pathway could represent an effective strategy to reduce the impact of high-fat diet-induced type 2 diabetes.